We are developing products in the following fields of use;
Treats all types of bacteria including MRSA, VRE and other flesh eating bacteria. Fights drug resistant bacteria. $6B/year global market.
Onychomycosis, a fungal infection of the toenails, is a major health problem. It is estimated that there are in excess of 40 million sufferers with this condition in the USA. It is a problem throughout the world. A recent European study showed that the prevalence of Onychomycosis may be as high as 26.9%. Fungal resistance can occur when the oral antifungal agents are used on a long-term basis. Topically applied antifungal drugs may work somewhat better adjunctive to surgical removal or chemical dissolution of the nail plate. Yet, this often ineffective and traumatic procedure leaves the subject without a nail for months at risk for re-infection. Given the limitations of current treatment options in this $3B market, there is a great need for a simple, nontoxic and effective alternative treatment. Estimated Global prevalence rate: 140 million.
The current state of the world acne market is overcrowded with generics and alternative therapies, such as photodynamic therapy and UV/blue light therapy. According to GlobalData's research, "the global acne market was worth $2.8 billion in 2009. It is estimated to reach revenues of $3.02 billion by 2016 at a Compound Annual Growth Rate (CAGR) of 0.7%. Estimated Global prevalence rate: 650 million.
Psoriasis market is estimated to be worth about $2.4 billion. GIA announced the release of a comprehensive global report on Psoriasis drugs markets. The world market for psoriasis drugs is projected to exceed $7.3 billion by the year 2015. Estimated Global prevalence rate: 125 million.
GlobalData estimated the global eczema therapeutics market to value $2.5B in 2014. It is expected to grow to a value of $3.8B by 2018, at a compound annual growth rate (CAGR) of 8.2%. Estimated Global prevalence rate: 700 million.
Treats symptoms of Influenza which is a$4B/ year global market: Common
Diabetic foot wounds.